INTRODUCTION {#s1}
============

Similar to red meat species, poultry muscle fiber number is determined during prenatal development. Although red meat species' offspring in utero muscle development is heavily influenced by maternal factors ([@CIT0007]; [@CIT0006]), poultry have no such influence once the egg is laid. Although developing chicken embryos are not influenced by their hens, numerous studies stated nutrients within the egg were not sufficient to support maximal growth ([@CIT0014]; [@CIT0027]). This led scientists to explore in ovo feeding as a means to supply extra nutrients.

In ovo feeding is the practice of injecting compounds into various locations within the incubating egg. Initially, the technology was developed for vaccine administration ([@CIT0018]). In the literature, groups examined the effects of injecting compounds including growth hormone ([@CIT0009]; [@CIT0011]), amino acids ([@CIT0013]; [@CIT0002]), and insulin-like growth factor-1 (IGF-1; [@CIT0012]; [@CIT0021]) on muscle development. Others groups also demonstrated nutrient delivery using nanoparticles such as diamond ([@CIT0008]), platinum ([@CIT0015]), silver ([@CIT0017]), and gold ([@CIT0027]) affected muscle development. The literature does not indicate why the industry has not widely adopted these technologies, the fact that some compounds are toxic or subject to extra regulations may provide an explanation for lack of adoption. Therefore, identifying compounds that improve muscle development but are considered natural can be beneficial to the industry.

Nicotinamide riboside (NR), a new pyridine-nucleoside form of vitamin B3, occurs naturally at low concentrations in yeast, bacteria, and milk ([@CIT0005]). In mouse embryonic stem cells and young and aged mouse models, NR supplementation increased nicotinamide adenine dinucleotide (NAD^**+**^) levels ([@CIT0022], [@CIT0024]). [@CIT0016] reported sirtuin-1, a major consumer of NAD^+^, increased muscle satellite cell proliferation, and [@CIT0024] also found NR increased both NAD^+^ and satellite cell number in aged mice. Because NR influenced satellite cell number through increased NAD^+^ production, the compound could positively influence the events of chicken embryonic muscle growth and development. The hypothesis of the experiment was in ovo feeding of NR to the developing broiler embryo will increase pectoralis major (PM) muscle mass. The objective of this study was to examine the effects of NR in ovo feeding on broiler PM growth and development.

MATERIALS AND METHODS {#s2}
=====================

The methodology outlined below was approved by the Kansas State University Institutional Animal Care and Use Committee (Approval \# 3816.1).

Egg Procurement, Incubation, and Injections {#s3}
-------------------------------------------

Fertilized broiler eggs (*N* = 156; Cobb 500; Cobb-Vantress, Siloam Springs, AR) with an average weight of 70.3 g were transported in coolers to the Kansas State University Muscle Biology Laboratory (Manhattan, KS). Upon arrival, egg weights were recorded, eggs were ordered by weight, and within each four egg strata, eggs were randomly assigned to treatments within a 2 × 2 factorial arrangement. Factor 1 was NR treatment with eggs receiving 0 or 250 mM NR (ChromaDex, Los Angeles, CA). Factor 2 consisted of injection location, with treatments injected into either the yolk or albumen (Albumen 0 *n* = 27; Albumen 250 *n* = 32; Yolk 0 *n* = 30; Yolk 250 *n* = 24). After treatment assignment, eggs were positioned with equal treatment representation onto trays and placed in an incubator (Sportsman 1502; GQF Manufacturing Company Inc., Savannah, GA) set to operate at a temperature of 37 °C and a relative humidity of 40 ± 2% for the first 18 d of incubation. The incubator rotated hourly to reposition eggs and trays were rotated daily throughout the incubator to account for variation in temperature and humidity. Tray weights were recorded each day to determine egg weight loss percentage with a target weight loss of 0.67% per day.

Injection Procedure {#s4}
-------------------

At day 10 of incubation, NR with the equivalent weight of 250 mM was added to 0.9% sterile saline and covered with foil to prevent exposure to light. Sets of 20 eggs representing equal treatment numbers were removed from the incubator and candled to determine location of the yolk and albumen, and the injection site was cleaned with 70% ethanol. Eggs were turned at a 90° angle and a 2.54-cm, 20-guage hypodermic needle was used to create an opening in the shell at the proper injection site. The needle was inserted approximately 1 cm into injection site and 100 µL of the 250 mM NR solution or 0.9% saline solution was injected into the egg. A 1-cm^2^ portion of medical tape (Nexcare; 3M, Maplewood, MN) was positioned over the injection location and eggs were returned to the incubator.

Hatching, Euthanasia, and Processing {#s5}
------------------------------------

On day 18 of incubation, the relative humidity of the incubator was increased to 60 ± 2% and eggs were placed into hatching boxes at the bottom of the incubator. As chicks began to hatch, they were removed from the incubator, marked for treatment, and relocated to a box positioned underneath a heat lamp. Within 24 h after hatch, chicks were euthanized by prolonged exposure to CO~2~ gas and decapitation. Chick weights were recorded, and digital calipers (Traceable Digital Calipers; Fisher Scientific, Pittsburg, PA) were utilized to measure crown to rump length, head width, and head length. Head and chest circumference were also collected by wrapping a string around the designated area and determining the length against a ruler.

Chick carcasses were sprayed with 70% ethanol and the skin and feathers were pulled back to reveal the PM muscles. Prior to PM muscles removal, chest width and length were measured using digital calipers. The left and right PM muscles were removed, careful to not remove the PM muscles. The left PM was weighed, and dimensions were collected using digital calipers, including length, width, and depth. This muscle was positioned onto a tongue depressor and placed into a −80 °C freezer, where it was stored until it was used for cryosectioning. The heart and liver were also removed, weighed, and discarded.

Immunohistochemistry {#s6}
--------------------

The methods of [@CIT0028] were followed for immunohistochemistry with modifications. The PM was removed from the tongue depressor, embedded in tissue embedding media (Fisher Scientific), cooled with isopentane chilled liquid nitrogen, and stored at −80 °C until cryosectioning. Ten micrometer-thick cryosections were cut using a Microm 550 cryostat (Thermo Fisher Scientific, Kalamazoo, MI), and six cryosection were collected on positively charged slides (Diamond White Glass; Globe Scientific Inc., Paramus, NJ). Cryosections were incubated in a blocking solution containing 5% horse serum and 0.2% TritonX-100 in phosphate-buffered saline (PBS) for 30 min. Slides were incubated for 1 h at room temperature in a primary antibody solution consisting of blocking solution and 1:500 rabbit, α-dystrophin (Thermo Fisher Scientific). Cryosections were washed three times for 5 min each in PBS and incubated for an additional 30 min with blocking solution containing 1:1,000 Alexa-Flour 594 goat-anti-rabbit heavy and light chains (Life Technologies, Carlsbad, CA). Cryosections were washed again as stated above, 5 µL of 9:1 glycerol in PBS was placed on each section, and slides were coverslipped for imaging. Cryosections were visualized at 200× magnification using a Nikon Elipse TI-U inverted microscope (Nikon Instruments Inc., Melville, NY), a Nikon DS-QiMC digital camera (Nikon Instruments Inc.) was used to photograph cryosections, and an average of 1,000 fibers were analyzed using NIS-Elements imaging software (Basic Research, 3.3; Nikon Instruments Inc.) to determine fiber cross-section area (CSA).

Statistics {#s7}
----------

Data were analyzed as a completely randomized design with a 2 × 2 factorial arrangement and egg as the experimental unit. Nicotinamide riboside treatment (TRT) and injection location (LOC) and their interaction served as fixed effects. The PROC MIXED procedure of SAS 9.4 (SAS Inst. Inc., Cary, NC) was utilized, and pairwise comparisons between the least square means were computed using the PDIFF option of the LSMEANS statement. Differences were considered statistically significant at *P* \< 0.05.

RESULTS {#s8}
=======

There were no TRT × LOC interactions for all measures (*P* \> 0.07; [Table 1](#T1){ref-type="table"}), except PM weight and length (*P* \< 0.01). Pectoralis major weights of chicks injected with NR in the albumen were not different (*P* = 0.09) when compared with chicks injected with saline in the albumen; however, chicks injected with NR in the yolk had greater (*P* \< 0.01) PM weights than those injected with saline. Pectoralis major lengths of chicks injected with NR in the albumen were longer (*P* = 0.04) than those injected with saline. Lengths of chicks injected with NR in the yolk were longer (*P* \< 0.01) than those injected with saline, but the difference was greater than the albumen response.

###### 

Body and pectoralis major morphometrics of hatched chicks injected in ovo with nicotinamide riboside during embryogenesis

  Nicotinamide riboside dose^1^   0 mM       250 mM                *P*-value^2^                            
  ------------------------------- ---------- ---------- ---------- -------------- ------ -------- -------- --------
  Weight, g                       42.69      42.99      43.19      44.02          6.40   0.17     0.31     0.63
  Body measurements                                                                                        
   Dimensions, mm                                                                                          
    Crown-rump length             95.60      96.93      96.14      89.36          3.70   0.12     0.23     0.07
    Head width                    15.40      15.74      15.56      15.45          0.40   0.67     0.48     0.21
    Head length                   21.79      21.86      21.29      21.73          0.19   0.42     0.51     0.63
    Head circumference            32.38      32.08      32.14      31.49          1.60   0.70     0.66     0.87
    Chest length                  22.01      21.96      21.98      22.68          0.55   0.36     0.39     0.29
    Chest width                   16.90      17.35      16.57      17.69          0.33   0.98     0.01     0.28
   Heart weight, g                0.36       0.36       0.35       0.36           0.02   0.75     0.55     0.24
   Liver weight, g                1.09       1.08       1.05       1.11           0.06   0.64     0.36     0.19
  Pectoralis major measurements                                                                            
   Weight, g                      0.13^a^    0.13^a^    0.14^a^    0.18^b^        0.01   \<0.01   \<0.01   \<0.01
   Dimensions, mm                                                                                          
    Length                        17.55^a^   17.04^a^   18.68^b^   20.74^c^       0.43   \<0.01   0.06     \<0.01
    Width                         4.59       4.62       4.81       5.21           0.22   \<0.01   0.13     0.20
    Depth                         2.27       2.32       2.43       2.65           0.09   \<0.01   0.09     0.30

^abc^Treatments with different superscripts within a row differ (*P* \< 0.05).

^1^100 µL of 0.9% saline containing 0 or 250 mM nicotinamide riboside injected at day 10 of incubation.

^2^TRT denotes nicotinamide riboside treatment main effect; LOC denotes injection location main effect.

^3^Treatments were injected into either the yolk sac or albumen of the egg.

Treatment did not affect whole-body or organ measures (*P* \> 0.12); however, NR treatment did increase PM weight, length, width, and depth (*P* \< 0.01). There were no LOC main effects for all measures (*P* \> 0.06), with the exception of an increased chest width and PM weight when injection took place in the yolk (*P* = 0.01).

There were no TRT × LOC interaction or LOC and TRT main effects for muscle fiber CSA (*P* \> 0.06; [Fig. 1](#F1){ref-type="fig"}). There was a TRT × LOC interaction for muscle fiber density (*P* \< 0.01). Chicks injected with NR in the albumen did not differ (*P* = 0.09) in fiber density when compared with chicks injected with saline in the albumen; however, chicks injected with NR in the yolk had more (*P* \< 0.01) muscle fibers than those injected with saline. The TRT main effect did not affect (*P* = 0.06) muscle fiber density, but chicks injected in the yolk had more (*P* \< 0.01) fibers than chicks injected in the albumen.

![(a) Muscle fiber cross-sectional area (CSA) and (b) density of hatched chicks fed in ovo with nicotinamide riboside (NR) during embryogenesis. At day 10 of incubation, embryos were injected with 100 µL of 0.9% saline containing 0 or 250 mM NR in the yolk sac or albumen. Immunohistochemistry and muscle fiber morphometric data collection were conducted as described by [@CIT0028]. ^a,b^Means with different superscripts differ (*P* \< 0.05).](txaa126f0001){#F1}

DISCUSSION {#s9}
==========

Of the major protein-producing industries, the broiler industry has made the greatest advancement in production efficiency and yield. [@CIT0019] reported over a 25-yr period ending in 2010, broiler market weight increased almost 75% on only 0.44 kg more feed. Genetic selection and advancements in nutrient utilization are factors responsible for improved production efficiency ([@CIT0003]). Aside from efficiency of nutrient utilization, the most notable improvement in broiler production is the amount of deposited carcass muscle. Although not commonly practiced in industry, several researchers have explored in ovo feeding as a means to provide extra nutrients to maximize avian growth during embryogenesis. In the current study, in ovo feeding of NR did not affect any whole-body morphometric measurements or heart and liver weight. Opposite to the findings of the current study, [@CIT0001] and [@CIT0013] found in ovo feeding of amino acids in the yolk sac increased embryo and hatched chick weights. [@CIT0025] also reported hatched chick body weight increased when creatine pyruvate was fed to developing embryos in the amnion. [l]{.smallcaps}-Carnitine is a supplement that produces NAD^+^ similar to the salvage pathway NR operates through. Similar with the current study, in ovo injection of [l]{.smallcaps}-carnitine, into the amnion of the developing embryo at day 18 did not affect hatched chick body weight ([@CIT0023]). These findings indicate improvement in whole-body morphometrics may be dependent on the compound injected into the egg.

Even though whole-body measures were unaffected by NR injection, administration of NR into the yolk sac increased PM weight and length by 38% and 22%, respectively. Regardless of injection location, NR also increased PM width and depth by 9% and 11%, respectively. No other studies have examined the effect of NR on broiler embryo development; however, [@CIT0012] reported IGF-1 injected into the albumen of 12-d incubated duck embryos increased 27-d embryo and 2-d post-hatchling PM weight by 5.5% and 5.8%, respectively. [@CIT0010] found broilers injected with IGF-1 at days 15 or 16 of incubation had larger day 42 post-hatch breast muscles 19% and 17%, respectively. [@CIT0020] reported day 17 incubated embryos fed a cocktail to maintain glucose homeostasis increased hatched chick PM weight by 10% and this advantage was extended to 15% by day 25 of post-hatch growth. Despite not measuring PM weight at hatch, [@CIT0025] found chickens in ovo fed creatine pyruvate had greater PM weights at days 21 and 42 post-hatch by 21% and 13%, respectively. When compared with these studies, the NR treatment administered in the present study had a greater effect on PM development and growth and these advantages may be increased as the bird grows post-hatch.

The two major events of broiler embryo muscle development include primary muscle fiber formation, followed by secondary muscle fiber formation ([@CIT0029]). Primary myogenesis in the avian embryo encompasses days 3 to 7 of incubation and secondary myogenesis occurs from day 8 until hatch ([@CIT0004]). In the current study, in ovo feeding occurred at day 10 of incubation which is well into the events of secondary myogenesis. Feeding NR at this time period did not affect PM fiber CSA, but injecting NR into the yolk sac increased PM fiber density by 45%. While [@CIT0025] did not measure muscle fiber number or density, the authors found feeding creatine pyruvate increased post-hatch day-21 and -42 PM fiber CSA by 30% and 14%, respectively. [@CIT0012] demonstrated injecting IGF-1 into developing duck embryos did not affect breast muscle CSA or fiber density, but injections increased leg muscle CSA and density when embryos were harvested 1 d prior to hatch. [@CIT0026] reported injecting gold nanoparticles and taurine together or separately increased PM cell number by a maximum of 43%, and only injecting a combination of the molecules increased fiber diameter by 37%. Therefore, the NR response documented in the current study elicited the greatest increase in PM fiber density of known in ovo feeding studies, which caused the increased PM weight.

IMPLICATIONS {#s10}
============

Nicotinamide riboside is a novel vitamin B~3~ analog that has not been extensively utilized in poultry production. Because NR increases NAD^+^ production in tissues and the sirtuin-1 protein regulates stem cell activity in response to NAD^+^ levels, this is the possible mechanism by which NR increased PM weight and fiber density. Currently, it is unknown if the increased PM weight stimulated by in ovo NR feeding will affect future growth and meat quality; however, the NR response could affect the poultry industry yields, product quality, or incidence of myopathys; all which are future areas of research.
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